Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2018 Oct 30;66(2):e27524. doi: 10.1002/pbc.27524

Table 2.

Toxicities observed among the 39 cycles of chemotherapy administered to 19 patients enrolled on AOST1322

Toxicity Grade
No toxicity or < grade 3 Grade 3 or Greater
Number (Percent) Number (Percent)
Organ System Toxicity Type
Respiratory/Thoracic/Mediastinal Atelectasis 38 (97.4) 1 (2.6)
Dyspnea 38 (97.4) 1 (2.6)
Hypoxia 38 (97.4) 1 (2.6)
Injury/Poisoning/Procedural Fracture 38 (97.4) 1 (2.6)
Metabolism/Nutrition Hyponatremia 38 (97.4) 1 (2.6)
Investigations Neutrophil count decreased 32 (82.1) 7 (17.9)
White blood cell decreased 37 (94.9) 2 (5.1)
Musculoskeletal/Connective Pain in extremity 37 (94.9) 2 (5.1)
Cardiac Pericardial effusion 38 (97.4) 1 (2.6)
HHS Vulnerability Disclosure